Advertisement
Advertisement

NAUT

NAUT logo

Nautilus Biotechnology Inc

1.89
USD
-0.09
-4.54%
Dec 18, 15:14 UTC -5
Open

Nautilus Biotechnology Inc Profile

About

Nautilus Biotechnology Inc. is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the proteome. Nautilus Biotechnology Inc., formerly known as Arya Sciences Acquisition Corp III, is based in SEATTLE.

Info & Links

CEO

Sujal Patel

Headquarters

2701 EASTLAKE AVENUE EAST
SEATTLE, WA 98102, UNITED STATES

Auditor

PricewaterhouseCoopers LLP

Share holders

35

Employees

167

Nautilus Biotechnology Inc Statistics

Valuation Measures

Market Capitalization2

237.31M

Enterprise Value

232.90M

Enterprise Value/EBITDA(ttm)

-2.99

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

1.10

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-28.85%

Return on Invested Capital(ttm)

-28.94%

Return on Assets(ttm)

-24.93%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-77.90M

Net Income Available to Common(ttm)

-70.21M

Diluted EPS(ttm)

-0.56

Share Statistics

Beta (5Y Monthly)

1.14

52-Week Change

-35.49%

S&P 500 52-Week Change

25.92%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

125.56M

Dividend Yield

0.00%

Float4

74.71M

% Held by Insiders

40.50%

% Held by Institutions

50.71%

Balance Sheet

Total Cash(mrq)

140.61M

Total Cash Per Share(mrq)

1.12

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

16.65%

Quick Ratio(mrq)

16.65%

Book Value Per Share(mrq)

1.78

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.36

Free Cash Flow(ytd)

-46.70M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement